S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Conformis, Inc. stock logo
CFMS
Conformis
$2.26
$2.25
$1.05
$7.25
$17.80M1.3999,585 shs7,000 shs
Histogenics Corp stock logo
HSGX
Histogenics
$1.44
-9.4%
$1.33
$0.08
$1.43
$136.22M3.19.06 million shs7.15 million shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$15.80
-0.6%
$16.95
$10.60
$19.66
$116.45M0.4722,812 shs17,502 shs
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$1.39
$2.66
$1.30
$7.12
$5.64M1.2823,434 shs14,814 shs
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
$0.94
$0.56
$1.30
$63.04M2.3541,468 shs303,600 shs
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Conformis, Inc. stock logo
CFMS
Conformis
0.00%0.00%0.00%0.00%+37.80%
Histogenics Corp stock logo
HSGX
Histogenics
0.00%-7.02%+47.22%+183.88%+98.70%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
+0.82%-8.78%-0.69%-10.48%+26.61%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-7.95%-21.02%-47.35%-49.82%-78.16%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
0.00%0.00%0.00%+0.97%+61.48%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/AN/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
4.306 of 5 stars
0.05.01.74.92.21.73.1
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/AN/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Conformis, Inc. stock logo
CFMS
Conformis
2.00
HoldN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
N/AN/AN/AN/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
3.00
Buy$3.00∞ Upside

Current Analyst Ratings

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Conformis, Inc. stock logo
CFMS
Conformis
$57.06M0.31N/AN/A$4.07 per share0.56
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/A($0.01) per shareN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$124.69M0.93$1.39 per share11.34$16.76 per share0.94
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
$1.78M3.17N/AN/A$2.04 per share0.68
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
$5.51M0.00N/AN/A$1.10 per share0.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Conformis, Inc. stock logo
CFMS
Conformis
-$50.47M-$5.61N/AN/AN/A-72.72%-86.46%-47.65%N/A
Histogenics Corp stock logo
HSGX
Histogenics
-$8.64M-$0.79N/AN/AN/A-34.96%18.40%N/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$5.43M$0.7122.2510.75N/A4.33%6.63%5.45%6/5/2024 (Estimated)
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
-$13.98M-$3.47N/AN/A-785.62%-104.21%-70.49%5/20/2024 (Estimated)
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
-$19.57M-$0.37N/AN/AN/A-238.35%-29.00%-25.27%N/A

Latest LAKE, CFMS, HSGX, RWLK, and POAI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/10/2024Q4 2024
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.30$0.22-$0.08$0.57$32.50 million$31.20 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Conformis, Inc. stock logo
CFMS
Conformis
N/AN/AN/AN/AN/A
Histogenics Corp stock logo
HSGX
Histogenics
N/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.120.76%N/A16.90%N/A
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/AN/AN/AN/AN/A
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/AN/AN/AN/AN/A

Latest LAKE, CFMS, HSGX, RWLK, and POAI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/1/2024
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Quarterly$0.030.66%2/14/20242/15/20242/22/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Conformis, Inc. stock logo
CFMS
Conformis
0.64
5.07
3.30
Histogenics Corp stock logo
HSGX
Histogenics
N/A
4.05
4.05
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.01
5.53
2.74
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
N/A
2.55
2.43
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
N/A
3.47
2.99

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Conformis, Inc. stock logo
CFMS
Conformis
10.31%
Histogenics Corp stock logo
HSGX
Histogenics
40.35%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
71.69%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
9.04%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
3.58%

Insider Ownership

CompanyInsider Ownership
Conformis, Inc. stock logo
CFMS
Conformis
3.80%
Histogenics Corp stock logo
HSGX
Histogenics
19.70%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
6.10%
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
3.44%
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
2.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Conformis, Inc. stock logo
CFMS
Conformis
2957.88 million7.58 millionNot Optionable
Histogenics Corp stock logo
HSGX
Histogenics
4994.60 millionN/ANot Optionable
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
1,7507.37 million6.92 millionOptionable
Predictive Oncology Inc. stock logo
POAI
Predictive Oncology
314.06 million3.92 millionNot Optionable
ReWalk Robotics Ltd. stock logo
RWLK
ReWalk Robotics
5660.03 million58.76 millionOptionable

LAKE, CFMS, HSGX, RWLK, and POAI Headlines

SourceHeadline
VA STAND Act introduced in the United States SenateVA STAND Act introduced in the United States Senate
globenewswire.com - March 22 at 8:30 AM
4 Must-Buy Efficient Stocks to Increase Your Portfolio Returns4 Must-Buy Efficient Stocks to Increase Your Portfolio Returns
zacks.com - March 19 at 8:36 AM
COMP.4500 Mobile Robotics (Formerly 91.450)COMP.4500 Mobile Robotics (Formerly 91.450)
uml.edu - March 18 at 4:46 AM
Lifeward Announces Reverse Share SplitLifeward Announces Reverse Share Split
globenewswire.com - March 13 at 11:45 AM
ReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke TherapyReStore Exo-Suit Publications Demonstrate Improved Walking Outcomes Versus Conventional Stroke Therapy
globenewswire.com - March 8 at 8:30 AM
Lifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be consideredLifeward announces the Centers for Medicare & Medicaid Services (“CMS”) is deferring its final decision on the payment rate for personal exoskeletons so that more recent claims information on the current, more advanced ReWalk Personal Exoskeleton may be considered
globenewswire.com - March 1 at 8:45 AM
ReWalk Robotics (LFWD) Reports Q4 Loss, Misses Revenue EstimatesReWalk Robotics (LFWD) Reports Q4 Loss, Misses Revenue Estimates
zacks.com - February 27 at 10:16 AM
Lifeward Reports Fourth Quarter and Full Year 2023 Financial ResultsLifeward Reports Fourth Quarter and Full Year 2023 Financial Results
globenewswire.com - February 27 at 8:00 AM
Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024Lifeward to Report Fourth Quarter and Fiscal Year-End 2023 Financial Results on February 27, 2024
globenewswire.com - February 20 at 8:30 AM
Rewalk Robotics Ltd (LFWD)Rewalk Robotics Ltd (LFWD)
uk.investing.com - February 15 at 7:55 AM
Rewalk Robotics Ltd (RWLK)Rewalk Robotics Ltd (RWLK)
uk.investing.com - February 15 at 7:55 AM
ReWalk Robotics Ltd.ReWalk Robotics Ltd.
cnn.com - February 13 at 9:22 AM
7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market
finance.yahoo.com - February 6 at 5:23 PM
ReWalk Robotics looks to the future following Lifeward rebrandReWalk Robotics looks to the future following Lifeward rebrand
massdevice.com - February 5 at 10:12 AM
ReWalk Robotics Ltd. (DBA Lifeward): ReWalk Robotics Transforms Company Identity, Rebrands as LifewardReWalk Robotics Ltd. (DBA Lifeward): ReWalk Robotics Transforms Company Identity, Rebrands as Lifeward
finanznachrichten.de - January 31 at 10:29 PM
Rewalk Robotics Rebrands as Lifeward, Announces New TickerRewalk Robotics Rebrands as Lifeward, Announces New Ticker
msn.com - January 31 at 5:29 PM
Following acquisition, ReWalk rebrands to new name to reflect broader offeringsFollowing acquisition, ReWalk rebrands to new name to reflect broader offerings
wbjournal.com - January 29 at 1:02 PM
ReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past weekReWalk Robotics (NASDAQ:RWLK investor five-year losses grow to 82% as the stock sheds US$10m this past week
finance.yahoo.com - January 15 at 10:12 AM
ReWalk Robotics Expands Direct Sales Coverage to CanadaReWalk Robotics Expands Direct Sales Coverage to Canada
finance.yahoo.com - January 12 at 1:43 PM
ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17ReWalk Robotics Ltd. to Present at Sidoti Virtual Investor Conference on January 17
finance.yahoo.com - January 11 at 8:35 PM
ReWalk Robotics Ltd.: First ReWalk Personal Exoskeleton Claim Paid by MedicareReWalk Robotics Ltd.: First ReWalk Personal Exoskeleton Claim Paid by Medicare
finanznachrichten.de - January 5 at 4:14 PM
First ReWalk Personal Exoskeleton Claim Paid by MedicareFirst ReWalk Personal Exoskeleton Claim Paid by Medicare
finance.yahoo.com - January 5 at 9:07 AM
ReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational PrioritiesReWalk Robotics CEO Issues Year-End 2023 Open Letter to Shareholders and Provides 2024 Commercial and Operational Priorities
finance.yahoo.com - January 4 at 9:23 AM
Investing in Rewalk Robotics Ltd [RWLK]: What You Must KnowInvesting in Rewalk Robotics Ltd [RWLK]: What You Must Know
knoxdaily.com - January 1 at 5:41 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Conformis logo

Conformis

NASDAQ:CFMS
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, iTotal CR, and iTotal PS, as well as provides iTotal Identity and Identity Imprint knee replacement products. It also offers Conformis Hip System and Cordera hip replacement, which are hip replacement products; and iJigs, a personalized single-use patient-specific instrumentation. The company markets and sells its products to orthopedic surgeons, hospitals, and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Spain, Portugal, the Netherlands, Belgium, the Dutch Antilles, Suriname, Australia, Brazil, the United Arab Emirates, the Sultanate of Oman, Italy, Poland, and other markets. Conformis, Inc. was incorporated in 2004 and is headquartered in Billerica, Massachusetts.
Histogenics logo

Histogenics

NASDAQ:HSGX
Histogenics Corporation develops restorative cell therapies that would offer rapid-onset pain relief and restored function. The company was founded in 2000 and is headquartered in Waltham, Massachusetts.
Lakeland Industries logo

Lakeland Industries

NASDAQ:LAKE
Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.
Predictive Oncology logo

Predictive Oncology

NASDAQ:POAI
Predictive Oncology Inc. operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples. It operates through four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment provides services that include the application of AI, collaboration projects, and clinical testing. The zPREDICTA segment develops organ-specific disease models that provide 3D reconstruction of human tissues representing each disease state and mimicking drug response for testing of anticancer agents. The Soluble segment provides services using a self-contained automated system that conducts self-interaction chromatography screens using additives and excipients included in protein formulations resulting in soluble and physically stable formulations for biologics. This segment also offers protein stability analysis services; protein solubility kits that allow rapid identification of soluble formulations; and proprietary technologies for bacterial endotoxin detection and removal. The Skyline segment provides STREAMWAY System, a wall-mounted fully automated system, which virtually eliminates exposure to blood, irrigation fluid, and other infectious fluids found in the healthcare environment. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is headquartered in Eagan, Minnesota.
ReWalk Robotics logo

ReWalk Robotics

NASDAQ:RWLK
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.